Acknowledgement
본 연구는 2020년도 부산대학교 병원 임상연구비 지원으로 이루어 졌음.
References
- Ammar H, Rober JF. The diagnosis and management of idiosyncratic drug-induced liver injury. Liver Int 2019;39(1):31-41. https://doi.org/10.1111/liv.13931
- Bjornsson ES. Epidemiology, predisposing factors, and outcomes of drug-induced liver injury. Clin Liver Dis 2020;24(1):1-10 https://doi.org/10.1016/j.cld.2019.08.002
- European Association for the Study of the Liver. EASL Clinical Practice Guidelines: drug-induced liver injury. J Hepatol 2019;70(6):1222-61. https://doi.org/10.1016/j.jhep.2019.02.014
- Low EXS, Zheng Q, Chan E, Lim SG. Drug induced liver injury: East versus west. a systematic review and meta-analysis. Clinical and Molecular Hepatology 2020;26(2):142-54. https://doi.org/10.3350/cmh.2019.1003
- Dev K. Drug-induced liver injury. Clin Med 2016;16(6):104-9.
- An SY, Joo SH, Hur SY, Jang EG, Lee JH, Kim YC. A case report of efficacy of saenggan-tang on a patient with drug induced liver injury. J Int Korean Med 2019;40(2):201-7. https://doi.org/10.22246/jikm.2019.40.2.201
- Shin WJ, Kim TY, Park YJ, Moon JH, Ko H, Kim GT, et al. One case of drug-induced liver injury after taking gamiyukgunja-tang. Korean J Orient Int Med 2011;32(3):444-50.
- Lee BR, Kim WI. A case report of the effect of korean medicine on liver function test of drug-induced liver injury patient treated with western medicine. Official Journal of The Korean Medicine Society For The Herbal Formula Study 2014;22(1):193-200.
- Son CG. A Drug-Induced Liver Injury by Western Medication. J Int Korean Med 2015;36(1):69-75. https://doi.org/10.13048/jkm.15034
- Kim JH, Cho JH, Son CG. A case report for a toxic liver injury caused by voluntary administration of smilacis chinae radix. Korean J Orient Int Med 2012;33(4):609-14.
- Park SJ, Lee HM, Kang YK, Jeon SH, Kim JW. A case study of herbal medicine-induced liver injury improved with taeumjowe-tang(taiyintiaowei-tang). Journal of Sasang Constitutional Medicine 2010;22(2):135-42.
- Kim JY. Disease of digestive system. Seoul: ilchokak; 2016, p. 741-5.
- Kasper DL, Fauci AS, Hauser SL, Longo DL, Jameson JL, Loscalzo J. Harrison's principles medicine. 19th edition. New York: McGraw-Hill; 2015, p. 2897-99.
- Aida OA, Camilla S, M.Isabel L, Raul JA. Case characterization, clinical features and risk factors in drug-induced liver injury. Int J Mol Sci 2016;17(5):714. https://doi.org/10.3390/ijms17050714
- Benichou C, Danan G, Flahault A. Causality assessment of adverse reactions to drugs-II. An original model for validation of drug causality assessment methods: case reports with positive rechallenge. J Clin Epidemiol 1993;46(11):1331-6. https://doi.org/10.1016/0895-4356(93)90102-7
- Yvette NL. Rosuvastatin/ezetimibe: a review in hypercholesterolemia. Am J Cardiovasc Drugs 2020;20(4):381-92. https://doi.org/10.1007/s40256-020-00421-1
- Ballantyne CM. Ezetimibe: efficacy and safety in clinical trials. Eur Heart J Suppl 2002;4 (Supplement J):J9-J18. https://doi.org/10.1016/S1520-765X(02)90077-5
- Davidson MH, Ballantyne CM, Kerzner B, Melani L, Sager PT, Lipka L, et al. Efficacy and safety of ezetimibe coadministered with statins: randomised, placebo-controlled, blinded experience in 2382 patients with primary hypercholesterolemia. Int J Clin Pract 2002;58(8):746-55. https://doi.org/10.1111/j.1368-5031.2004.00289.x
- 경락경혈학 교재편찬위원회. 대한경락경혈학 제7판. 대전: 종려나무; 2016, p. 353-485.